210 related articles for article (PubMed ID: 11344217)
1. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.
Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2001 May; 86(5):2125-35. PubMed ID: 11344217
[TBL] [Abstract][Full Text] [Related]
2. Estradiol up-regulates antiapoptotic Bcl-2 messenger ribonucleic acid and protein in tumorigenic ovarian surface epithelium cells.
Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
Endocrinology; 2001 Jun; 142(6):2351-60. PubMed ID: 11356682
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
[TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphate activates mitogen-activated protein kinase in pre-neoplastic and neoplastic ovarian surface epithelial cells.
Choi KC; Tai CJ; Tzeng CR; Auersperg N; Leung PC
Biol Reprod; 2003 Jan; 68(1):309-15. PubMed ID: 12493727
[TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone activates mitogen-activated protein kinase in preneoplastic and neoplastic ovarian surface epithelial cells.
Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2002 May; 87(5):2245-53. PubMed ID: 11994371
[TBL] [Abstract][Full Text] [Related]
6. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
7. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
Erämaa M; Hildén K; Tuuri T; Ritvos O
Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
[TBL] [Abstract][Full Text] [Related]
8. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
[TBL] [Abstract][Full Text] [Related]
9. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
Roberts VJ; Barth S; el-Roeiy A; Yen SS
J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
[TBL] [Abstract][Full Text] [Related]
10. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
11. Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells.
Choi KC; Auersperg N; Leung PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):5075-8. PubMed ID: 11600588
[TBL] [Abstract][Full Text] [Related]
12. Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells.
Dalkin AC; Gilrain JT; Bradshaw D; Myers CE
Endocrinology; 1996 Dec; 137(12):5230-5. PubMed ID: 8940339
[TBL] [Abstract][Full Text] [Related]
13. Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.
Wong AS; Roskelley CD; Pelech S; Miller D; Leung PC; Auersperg N
Exp Cell Res; 2004 Sep; 299(1):248-56. PubMed ID: 15302591
[TBL] [Abstract][Full Text] [Related]
14. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta modulates inhibin A bioactivity in the LbetaT2 gonadotrope cell line by competing for binding to betaglycan.
Ethier JF; Farnworth PG; Findlay JK; Ooi GT
Mol Endocrinol; 2002 Dec; 16(12):2754-63. PubMed ID: 12456797
[TBL] [Abstract][Full Text] [Related]
16. Regulation of prostate branching morphogenesis by activin A and follistatin.
Cancilla B; Jarred RA; Wang H; Mellor SL; Cunha GR; Risbridger GP
Dev Biol; 2001 Sep; 237(1):145-58. PubMed ID: 11518512
[TBL] [Abstract][Full Text] [Related]
17. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
Wong AS; Pelech SL; Woo MM; Yim G; Rosen B; Ehlen T; Leung PC; Auersperg N
Oncogene; 2001 Mar; 20(11):1318-28. PubMed ID: 11313876
[TBL] [Abstract][Full Text] [Related]
20. Regulation of endometrial adenocarcinoma cell proliferation by Activin-A and its modulation by 17beta-estradiol.
Di Simone N; Schneyer AL; Caliandro D; Castellani R; Caruso A
Mol Cell Endocrinol; 2002 Jun; 192(1-2):187-95. PubMed ID: 12088879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
